These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5075556)

  • 1. Checking compliance of epileptic patients.
    Livingston S; Berman W
    N Engl J Med; 1972 Nov; 287(18):934. PubMed ID: 5075556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 3. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
    Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
    Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between dose and serum concentrations of carbamazepine, phenytoin, phenobarbital, and primidone in a Sri Lankan population compared with a European population.
    Peiris JB; Karunanayake EH; Joice PD; Goedhart DM; Meijer JW; Meinardi H
    Epilepsia; 1988; 29(5):564-70. PubMed ID: 3409842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of measuring anticonvulsant blood levels in epilepsy.
    Brett E
    Dev Med Child Neurol; 1977 Apr; 19(2):245-51. PubMed ID: 323092
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
    Driessen O; Höppener R
    Eur Neurol; 1977; 15(3):135-42. PubMed ID: 852469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Repetitive serum determinations of anticonvulsants in epileptic patients].
    Guerreiro CA; Ramos MC; Annes M
    Arq Neuropsiquiatr; 1993 Mar; 51(1):36-40. PubMed ID: 8215928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
    Schmidt D; Einicke I; Haenel F
    Arch Neurol; 1986 Mar; 43(3):263-5. PubMed ID: 3947275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary observations of serum carbamazepine concentration in epileptic patients.
    Cereghino JJ; Meter JC; Brock JT; Penry JK; Smith LD; White BG
    Neurology; 1973 Apr; 23(4):357-66. PubMed ID: 4736124
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measurement of the blood concentration of antiepileptic drugs. II Special cases].
    Loiseau P; Brachet A; Henry P
    Nouv Presse Med; 1975 May; 4(21):1573-6. PubMed ID: 765962
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin and phenobarbitone plasma clearance during pregnancy.
    Mygind KI; Dam M; Christiansen J
    Acta Neurol Scand; 1976 Aug; 54(2):160-6. PubMed ID: 821304
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma anticonvulsant concentrations during pregnancy.
    Lander CM; Edwards VE; Eadie MJ; Tyrer JH
    Neurology; 1977 Feb; 27(2):128-31. PubMed ID: 556828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy.
    Bäckström T; Jorpes P
    Acta Neurol Scand; 1979 Mar; 59(2-3):63-71. PubMed ID: 452841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum concentrations of phenobarbital and fenitoin in the ambulatory treatment of epileptic patients].
    Pascu I; Popoviciu L; Iazigian A; Gondaş M; Micu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):277-80. PubMed ID: 531392
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-epileptic drug intake adherence. The value of the blood drug level measurement and the clinical approach.
    Gomes Mda M; Maia Filho Hde S; Noé RA
    Arq Neuropsiquiatr; 1998 Dec; 56(4):708-13. PubMed ID: 10029871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.